Krishnaveni Reddy

Datos Biográficos

ID	7561365
NOMBRE	Krishnaveni Reddy
NOMBRES	Krishnaveni
APELLIDO	Reddy
FIRMA	REDDY K
AFILIACIONES	University of the Witwatersrand
ORCID	0000-0002-3881-2704
VERIFICADO	Sí
TOTAL DE OBRAS	26
TOTAL DE CITAS	0
TOTAL COMO AUTOR	26
TOTAL COMO EDITOR	0
PRIMER AÑO DE PUBLICACIÓN	2017
AÑO MÁS RECIENTE DE PUBLICACIÓN	2026
ÍNDICE H	0

Development of a Self-administered Sexual Behavior Assessment Tool to Facilitate Self-reflection by Young Women in South Africa About HIV/STI Risk
Open AccessKrishnaveni Reddy, Jiaying Hao et al.ARTICLEAIDS and Behavior2026
Self-assessment of sexual behavior may empower adolescent girls and young women (AGYW) to reflect on HIV/STI risk and adopt prevention strategies. We developed a web-based sexual behavior self-assessment tool providing real-time feedback based on a numeric score and examined associations of scores with STI detection and HIV pre-exposure prophylaxis (PrEP) initiation among AGYW in South Africa. The tool was implemented as part of PALESA, a pilot r…
‘ … They Just Take One Pill, So It Is Easy to Use, More Convenient … ’
Open AccessS Mathur, Siyanda Tenza et al.ARTICLESAHARA-J Journal of Social…2026
The Dual Prevention Pill (DPP) is a daily oral pill containing oral pre-exposure prophylaxis (PrEP) for protection against HIV and a combined oral contraceptive (COC) for the prevention of unintended pregnancy, currently under development. However, little is known about healthcare providers' (HCPs) perspectives on this potential new multipurpose prevention technology (MPT). A more granular understanding of HCP views about the DPP may support effo…
Acceptability of the dapivirine vaginal ring for HIV-1 prevention among women reporting engagement in transactional sex
Erica N Browne, Kristine Torjesen et al.ARTICLEAIDS Care2024
We assessed if acceptability of the dapivirine vaginal ring for HIV prevention differed among the subgroup of women who reported engaging in transactional sex prior to enrollment in MTN-020/ASPIRE (phase III trial in Malawi, South Africa, Uganda, and Zimbabwe, 2012-2015; n = 2629). Transactional sex was defined as receipt of money, goods, gifts, drugs, or shelter in exchange for sex in the past year. Dimensions of acceptability included: ease of …
Correlates of Adherence to Oral and Vaginal Pre-exposure Prophylaxis (PrEP) Among Adolescent Girls and Young Women (Agyw) Participating in the MTN-034/Reach Trial
Open AccessKenneth Ngure, Erica N Browne et al.ARTICLEAIDS and Behavior2024
A latent trajectory analysis of young sexual and gender minorities’ adherence to three rectal microbicide placebo formulations (MTN-035; a randomized crossover trial)
Open AccessSeul Ki Choi, Jose Bauermeister et al.ARTICLEBMC Public Health2023
NCT03671239 (14/09/2018)
Understanding the role of men in women's use of the vaginal ring and oral PrEP during pregnancy and breastfeeding
Petina Musara, Miriam Hartmann et al.ARTICLEAfrican Journal of AIDS Research2022
We examined men's influence on women's interest in biomedical HIV prevention during pregnancy and breastfeeding through structured questionnaires and focus group discussions with currently or recently pregnant and breastfeeding (P/BF) women ( n = 65), men with P/BF partners ( n = 63) and mothers/mothers-in-law of P/BF women ( n = 68) in eastern and southern Africa. Data were transcribed, coded and summarised into analytical memos. Men were depict…
Examining Associations Between Mental Health, IPV Exposure, HIV Risk Behaviors, and PrEP Use in South African Women
Open AccessNoah S Triplett, Sarah T Roberts et al.ARTICLEAIDS and Behavior2022
Post-randomization Differences in Condomless Vaginal Sex Among Women Randomized to Intramuscular Depot Medroxyprogesterone Acetate Injections, a Copper Intrauterine Device or a Levonorgestrel Implant …
Open AccessJennifer Deese, Pai Lien Chen et al.ARTICLEAIDS and Behavior2022
The Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial found no substantial difference in HIV acquisition risk between women randomised to injectable intramuscular depot medroxyprogesterone acetate (DMPA-IM), copper intrauterine device (Cu-IUD) or the levonorgestrel (LNG) implant. We evaluated post-randomization sexual behavior using an objective marker of condomless vaginal sex in a subset of participants. We conducted a sub-study …
Efficacy and Action of the Dapivirine Vaginal Ring as Understood by Women Participating in an Open Label Extension Study
Open AccessKalendri Naidoo, Montgomery Elizabeth T et al.ARTICLEAIDS and Behavior2022
Intimate Partner Violence and Engagement in the HIV Care Continuum among Women in Sub-Saharan Africa
Open AccessSarah T Roberts, Ariane Van Der Straten et al.ARTICLEAIDS and Behavior2022
Women’s experience receiving drug feedback and adherence counseling in MTN-025/Hope - an HIV Prevention open-label trial of the Dapivirine Vaginal Ring
Open AccessAriana Katz, Iván C Balán et al.ARTICLEAIDS and Behavior2022
Ring-ing in the Future
Open AccessKrishnaveni Reddy, Florence Mathebula et al.ARTICLEAIDS and Behavior2022
Integrating Gender-Based Violence Screening and Support into the Research Clinic Setting
Open AccessMorgan Garcia, Sarah T Roberts et al.ARTICLEAIDS and Behavior2022
HIV and gender-based violence (GBV) are syndemic in sub-Saharan Africa and provision of support for participants who disclose GBV constitutes part of comprehensive care. Consequently, a process was undertaken to develop, implement, and evaluate standard operating procedures (SOPs) in MTN-025/HOPE, a study of the dapivirine vaginal ring for HIV prevention. The SOP was developed using needs assessment surveys in addition to World Health Organizatio…
Religious leaders’ role in pregnant and breastfeeding women’s decision making and willingness to use biomedical HIV prevention strategies
Alinda M Young, Julia Ryan et al.ARTICLECulture Health & Sexuality2022
Oral Pre-Exposure Prophylaxis (PrEP) is an established option, and the dapivirine vaginal ring is emerging as a promising strategy for HIV prevention option for women. Because of this, understanding the contextual and cultural factors that will support the increased uptake of these products is crucial. In sub-Saharan Africa, religious leaders may be important stakeholders to involve in product information, education and roll-out. We conducted a s…
Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/Aspire study
Open AccessMorgan Garcia, Ellen Luecke et al.ARTICLEBMC Public Health2021
Our analysis supports the growing body of work illustrating the importance of meaningfully engaging research participants to achieve study success and aligns with other analyses of adherence support efforts during ASPIRE. While causation between PEA attendance and product use cannot be established, residual drug levels in returned rings strongly correlated with participant attendance at PEAs, and the benefits of incorporating PEAs should be consi…
Does the Ring Work? Perceptions and Understanding of the Efficacy of a Dapivirine Vaginal Ring for HIV Prevention Amongst Women in a Placebo-Controlled Trial
Open AccessJuliane Etima, Ariana Katz et al.ARTICLEAIDS and Behavior2021
Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial
Open AccessAshley Mayo, Erica N Browne et al.ARTICLEAIDS and Behavior2021
We evaluated the acceptability of the 25 mg dapivirine vaginal ring (DVR) as an HIV prevention intervention and its influence on DVR adherence in the MTN-020/ASPIRE phase III trial. Acceptability measures were captured using ACASI at month 3 and end of product use (median 24 months, IQR 15-30). Monthly returned rings were classified as nonadherent if dapivirine release rate was ≤ 0.9 mg/month. Associations between acceptability measures and nonad…
Sexual Attitudes, Beliefs, Practices, and HIV Risk During Pregnancy and Post-delivery
Open AccessJulia Ryan, Alinda M Young et al.ARTICLEAIDS and Behavior2021
Women who acquire HIV during the pregnancy and breastfeeding periods have a higher risk of transmitting the virus to their child than women who become infected with HIV before pregnancy. We explore the context of sexual beliefs and practices that may shape both HIV risk and willingness to use HIV prevention products during pregnancy and postpartum in Malawi, South Africa, Uganda and Zimbabwe. Twenty-three single sex focus group discussions and 36…
Integration of a Relationship-focused Counseling Intervention with Delivery of the Dapivirine Ring for HIV Prevention to Women in Johannesburg
Open AccessElizabeth Montgomery, Sarah T Roberts et al.ARTICLEAIDS and Behavior2021
Impact of Women’s Home Environment on Use of the Dapivirine Vaginal Ring for HIV Prevention in Sub-Saharan Africa
Open AccessMargaret W Gichane, Ariana Katz et al.ARTICLEAIDS and Behavior2021
The Power of the Shared Experience
Open AccessAriana Katz, Kalendri Naidoo et al.ARTICLEAIDS and Behavior2020
Impact of Male Partner Involvement on Women’s Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial
Open Accessfor the MTN-020/ASPIRE Team, Sarah T Roberts et al.ARTICLEAIDS and Behavior2019
Hygiene, Blood Flow, and Vaginal Overload
Open Accessthe MTN-020/ASPIRE Study Team, Zoe Duby et al.ARTICLEAIDS and Behavior2019
Relationship Type and Use of the Vaginal Ring for HIV-1 Prevention in the MTN 020/Aspire Trial
Open Accessthe MTN-020/ASPIRE Study Team, Elizabeth Pleasants et al.ARTICLEAIDS and Behavior2019
Negative rumours about a vaginal ring for HIV-1 prevention in sub-Saharan Africa
Miria Chitukuta, Zoe Duby et al.ARTICLECulture Health & Sexuality2019
Rumours may influence health-related behaviours, including the uptake of and adherence to HIV prevention products. This study assessed the safety and effectiveness of a vaginal ring delivering the antiretroviral dapivirine for HIV prevention in Africa. We explored negative rumours about study participation and the vaginal ring amongst study participants and their communities in Malawi, Uganda, South Africa and Zimbabwe. In total 214 women partici…